About Sierra Nevada Oncology Care
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
CTI BioPharma
1
East Valley Hematology and Oncology Medical Group
1
Novartis Pharmaceuticals
1
Clinical Trials at Sierra Nevada Oncology Care
During the past decade, Sierra Nevada Oncology Care conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
2003-01-01
2009-04-01
Unknown status
180
A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.
2005-12-01
2006-12-01
Terminated
600
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Sierra Nevada Oncology Care"
#1 collaborator was "Astex Pharmaceuticals, Inc." with 1 trials as a collaborator, "Mena, Raul, M.D." with 1 trials as a collaborator and "Pharmatech Oncology" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Sierra Nevada Oncology Care
According to Clinical.Site data, the most researched conditions in "Sierra Nevada Oncology Care" are
"Chronic Lymphocytic Leukemia" (1 trials), "NSCLC" (1 trials), "Non-Small-Cell Lung Cancer" (1 trials) and "Pleural Effusion, Malignant" (1 trials). Many other conditions were trialed in "Sierra Nevada Oncology Care" in a lesser frequency.
Clinical Trials Intervention Types at Sierra Nevada Oncology Care
Most popular intervention types in "Sierra Nevada Oncology Care" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Nipent, Cytoxan, Rituxan" (1 trials), "paclitaxel" (1 trials), "paclitaxel poliglumex" (1 trials) and "zoledronic acid" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sierra Nevada Oncology Care
The vast majority of trials in "Sierra Nevada Oncology Care" are
2 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Sierra Nevada Oncology Care
Currently, there are NaN active trials in "Sierra Nevada Oncology Care".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Sierra Nevada Oncology Care,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Sierra Nevada Oncology Care, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".